secwatch.observer — SEC 8-K summary
======================================

Issuer:     STRYKER CORP (SYK)
CIK:        0000310764
Form:       8-K
Filed at:   2025-10-30T23:59:59+00:00
Accession:  0000310764-25-000126
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Stryker Q3 net sales +10.3% to $6.1B; raises FY 2025 guidance
-------------------------------------------------------------

- Reported EPS $2.22 (+2.8%); adjusted EPS $3.19 (+11.1%).
- Organic net sales +9.5% (volume +9.1%, price +0.4%); MedSurg/Neuro +8.4% organic.
- Orthopaedics organic +11.4% (ex-divested Spinal +12.5%); adjusted op margin 25.6% (+90 bps).
- FY 2025 guidance raised: organic sales growth 9.8%-10.2%, adj EPS $13.50-$13.60.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/310764/000031076425000126/0000310764-25-000126-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/310764/000031076425000126/syk-20251030.htm
  HTML page:      https://secwatch.observer/filing/0000310764-25-000126

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer